Retatrutide
$230.00 incl. GST
Triple-receptor metabolic research
Retatrutide is an investigational triple-receptor peptide studied in metabolic and weight-management research.
For laboratory research use only.
For laboratory research use only. Not intended for human consumption, diagnosis, treatment or therapeutic use.
Research, clearly documented.
Retatrutide is an investigational triple-receptor peptide studied in metabolic and weight-management research. It acts on GLP-1, GIP and glucagon pathways involved in appetite, glucose regulation and energy use. Clinical trials are ongoing; it is not an approved medicine, and research-grade products should not be presented as equivalent to trial or pharmaceutical material.
Research interests
- Appetite signalling
- Glucose regulation
- Energy use
- Body-weight research
Product specification: Retatrutide · 20 mg · Powder
Evidence context: Investigational compound in ongoing clinical development; not approved.
Research use only: This product is supplied strictly for laboratory research. It is not intended for human consumption, diagnosis, treatment or therapeutic use.
Additional information
| Research Category | METABOLIC |
|---|---|
| High-Level Role | Triple-receptor metabolic research |
| Common Research Interests | Appetite signalling, Glucose regulation, Energy use, Body-weight research |
| Strength | 20 mg |
| Form | Powder |
